Diamond
Gold
Silver
Confirmed Sponsors
The European Society of Cataract and Refractive Surgeons
Confirmed Sponsors
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care.
Being a truly global company, we work in 60 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
AbbVie has dedicated 75+ years to advancing eye care, launching 125+ products for prevalent eye conditions. We continue our commitment to helping ECPs deliver superior patient care through R&D, outreach programs, and educational support.
Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson and is composed of two divisions, Johnson & Johnson Surgical Vision and Johnson & Johnson Vision Care (Contact Lens).
Services include Intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastic, Microkeratomes and related products used in cataract and refractive surgery.
Johnson and Johnson Surgical Vision is based in Santa Ana, California, and Johnson & Johnson Vision Care is based in Jacksonville, Florida. JJV employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.
In February 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson.
STAAR Surgical designs, develops, manufactures, markets and implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. More than 2 million lenses have been distributed worldwide.
VSY Biotechnology Gmbh is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology and orthopedics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe.
Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems , viscoelastics for ophthalmology and orthopedics and hyaluronic acid (HA) viscosupplement products for orthopedics.
Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 90+ countries around the globe from our headquarters with a professional marketing and distribution approach.
With our know-how in biotechnology, we will continue to enlighten the world by combining these disciplines for the patients.
The company is owned by Evmann Investments Holding BV at 100%. Evmann Investments Holding BV is a Dutch resident Holding company which currently has investments in ophthalmology and orthopedics industries. Its strategy is to make investments especially in areas creating value for a healthier life under its motto of “Invest for Life”.
As one of the world’s leading medical technology companies, ZEISS Medical Technology is a visionary company at the forefront of healthcare’s digital transformation. ZEISS helps doctors all over the world improve their patients’ lives. With a special focus on ophthalmology, ophthalmic surgery and advanced visualization systems in the field of microsurgery, ZEISS supports healthcare professionals in setting new standards of more personalized, data-driven care with connected workflow solutions and proven diagnostic and treatment technologies based on a long history of cutting-edge innovation.
Bausch + Lomb is a leading global eye care company with over 170 years of expertise in ophthalmology. Our complete portfolio for anterior, posterior, premium and glaucoma surgery includes innovations such as the SeeLuma™ Fully Digital Surgical Visualization Platform and the Minimally Invasive Micro Sclerostomy (MIMS®) glaucoma procedure. The combined Stellaris Elite™ Vision Enhancement System, the LuxSmart™, IC-8® and enVista® premium IOLs, plus the Technolas® TENEO™ 317 M2 Excimer Laser feature in our range. Learn more on booth D35 Hall 7.
EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. With over 200,000 employees across 150 countries, 650 operations facilities and 18,000 stores, in 2023 the Company generated consolidated revenue of Euro 25.4 billion. Its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. EssilorLuxottica is home to the most advanced lens technologies including Varilux, Stellest and Transitions, the most iconic eyewear brands including Ray-Ban and Oakley, the most desired luxury licensed brands and world-class retailers including LensCrafters and Sunglass Hut. The Company’s OneSight EssilorLuxottica Foundation has given access to sustainable vision care to more than 760 million people in underserved communities.
Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
iSTAR Medical is committed to delivering breakthrough eye care solutions. Our most advanced product, MINIject®, is approved in Europe for the treatment of open-angle glaucoma – the leading cause of irreversible blindness – and we are aiming to seek market approval in the US. We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients.
MINIject® combines the distinctive porous structure of its proprietary STAR material with the power offered by the supraciliary space. As a result, it is designed to enhance natural fluid outflow, reducing intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis and subsequent complications.
LENSAR® designs, develops, and markets advanced systems for the treatment of cataracts and the management of astigmatism as an integral part of the cataract procedure. LENSAR developed its next-generation ALLY® Adaptive Cataract Treatment System, the first platform to integrate AI into its proprietary imaging with an optimized, dual-pulse laser in a compact system. ALLY is designed to transform cataract surgery by utilizing LENSAR’s advanced technologies to perform the entire procedure in a sterile operating room environment or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® technology, designed to guide surgeons to treat astigmatism and achieve better outcomes.
Rayner is leading the way in ophthalmic innovation with IOLs and ophthalmic solutions designed to provide surgeons and patients with the best visual outcomes. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.
With more than 70 years of continuous growth and experience, we now sell to over 80 countries. Our mission is to deliver innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in us to improve sight and quality of life.
Rayner has a broad portfolio of products across the patient pathway, including monofocal and premium Intraocular Lenses (IOLs), a full range of Ophthalmic Viscosurgical Devices (OVDs), a family of Ocular Surface Disease (OSD) solutions and RayPRO, our patient outcomes digital platform.
Rayner is a British company and the only manufacturer of intraocular lenses in the UK.
SCHWIND eye-tech-solutions stands as a pioneer in the refractive market, driving advanced solutions for vision correction procedures and building strong relationships with customers.
The SCHWIND AMARIS excimer and SCHWIND ATOS femtosecond laser systems cover an outstanding broad range of applications, from PRK, TransPRK (i.e. SmartSurfACE), LASEK, FemtoLASIK, PTK, TransPTK, CXL, and keratoplasty with the AMARIS product family to LASIK flap and lenticule extraction (i.e. SmartSight) with the ATOS. Another key differentiator is, that SCHWIND diagnostic devices are seamlessly integrated in the laser environment.